In focus · trending topic

Glioblastoma

2 stories · following the connections

VBI Vaccines Announces Positive DSMB Review in Phase 1/2a Study of VBI-1901 in Recurrent Glioblastoma (GBM) Patients

By Nasdaq OMXApr 17, 2018, 12:01 PM UTC

Profiling Brain Cancers for More Targeted Treatments

By Nasdaq OMXDec 22, 2017, 2:03 PM UTC